Skip to main content
. 2018 Nov 28;12(3):319–326. doi: 10.1007/s40271-018-0347-z

Fig. 3.

Fig. 3

Comparison of medians (with interquartile range) of DAS28-P among the groups with good, moderate or no EULAR response after the initial 6 months of treatment. a Baseline DAS28-P; b change in DAS28-P (Δ DAS28-P). DAS28 28-joint Disease Activity Score, DAS28-P patient-reported component of DAS28, EULAR European League Against Rheumatism